The Cancer Letter

Inside information on cancer research and drug development

In Brief

City of Hope Launches Blood Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

CITY OF HOPE launched an institute focused on treating blood and bone marrow diseases: the Hematologic Malignancies and Stem Cell Transplantation Institute.

The institute will be composed of six centers, individually focused on research in lymphoma, myeloma, leukemia, T cell immunotherapy, stem cell transplantation, and gene therapy. These include the Toni Stephenson Lymphoma Center and the Gehr Family Center for Leukemia Research.

The institute has recruited several prominent researchers, including Larry Kwak, chairman of the Department of Lymphoma/Myeloma at MD Anderson Cancer Center and associate director of its Center for Cancer Immunology Research; Jasmine Zain, associate director for the Bone Marrow Transplantation Program at the College of Physicians and Surgeons at the New York Presbyterian Hospital and Herbert Irving Comprehensive Cancer Center at Columbia University; John Chan, co-director of the Center for Leukemia and Lymphoma Research and co-leader of the Lymphoma Research Program at the University of Nebraska; Guido Marcucci, professor of internal medicine and molecular virology, immunology and medical genetics, and pharmaceutics in the Division of Hematology at Ohio State University Comprehensive Cancer Center; and Christiane Querfeld, dermatopathologist and lymphoma specialist at Memorial Sloan-Kettering Cancer Center.

The institute is currently launching several T cell immunotherapy clinical trials for treatment of leukemia and lymphoma, with others being developed for myeloma and transplantation.

Table of Contents

YOU MAY BE INTERESTED IN

White House

Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
By Paul Goldberg
Capitol Hill

With a spotlight on vaccines, abortion, Medicaid and Medicare, RFK Jr. goes before the Senate
The MAHA nominee trumpets radical transparency, but offers little clarity on his new agenda

In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
By Claire Marie Porter
Guest Editorial

Cancer research fuels life-saving work

Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
By Ze’ev Ronai
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account